Provider Identification:

This is the common website of the following companies:

Rentschler Biopharma SE
Erwin-Rentschler-Str. 21
88471 Laupheim 
Germany
P +49 7392 701-0
F +49 7392 701-300
info@rentschler-biopharma.com

Executive Board: Dr. Frank Mathias, Alexander Dettmer, Dr. Christian Schetter
Chairman of the Supervisory Board: Prof. Dr. Nikolaus F. Rentschler

Commercial Register Ulm HRB 731612
Turnover tax ID no.: DE299455159

 

Rentschler Biopharma Inc.
27 Maple Street
Milford, MA 01757
USA
P +1 508 282-5800
F +1 508 478-1883
info.us@rentschler-biopharma.com

President: Dr. Frank Mathias
Register Delaware 061127672 - 4265075

Responsible for the content of the website
Dr. Cora Kaiser

Applicable law

Law of the Federal Republic of Germany

The regulatory authority charged with monitoring the manufacturing of active ingredients, drug products and investigational products for clinical studies and responsible for issuing manufacturing licences:
Regierungspräsidium Tübingen
Referat 25 - Ärztliche und pharmazeutische Angelegenheiten
Konrad-Adenauer-Str. 20
72072 Tübingen
Germany
P +49 7071 757-0
F +49 7071 757-3190